Nucleic Acid Therapeutics: Impact Factor, Indexing, Publication Time & Fees


The Nucleic Acid Therapeutics is reputed journal publishes research related to Biochemistry (Q1); Drug Discovery (Q1); Genetics (Q1); Molecular Biology (Q1); Molecular Medicine (Q1). The ISSN of the journal is .

Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.

Nucleic Acid Therapeutics: Details

Journal TitleNucleic Acid Therapeutics
PublisherMary Ann Liebert Inc.
Publication CountryUnited States
ISSN21593345, 21593337
Publication AreaBiochemistry, Genetics and Molecular Biology; Pharmacology, Toxicology and Pharmaceutics
Publication LanguageENG
Review Process
Scopus IndexedYes

Nucleic Acid Therapeutics Impact Factor

The Impact Factor of Nucleic Acid Therapeutics in 2026 is 4.5.

Journal Quartile

The Nucleic Acid Therapeutics is ranked in Q2.

Indexing

The Nucleic Acid Therapeutics is indexed in: Web of Science.



Similiar journals to publish


Nucleic Acid Therapeutics
ISSN:
Publisher: Mary Ann Liebert Inc.
Journal Scope: Biochemistry (Q1); Drug Discovery (Q1); Genetics (Q1); Molecular Biology (Q1); Molecular Medicine (Q1)

Antisense and Nucleic Acid Drug Development
ISSN: 10872906
Publisher: Mary Ann Liebert Inc.
Journal Scope:

Current Protocols in Nucleic Acid Chemistry
ISSN: 19349270
Publisher: John Wiley & Sons Inc.
Journal Scope:

Progress in Nucleic Acid Research and Molecular Biology
ISSN: 796603
Publisher: Academic Press Inc.
Journal Scope:

Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme
ISSN: 399450
Publisher: Kyoritsu Shuppan Co., Ltd.
Journal Scope:

Pharmacology and Therapeutics Part C Clinical Pharmacology and Therapeutics
ISSN: 3625486
Publisher: Pergamon Press Ltd.
Journal Scope: